Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

When synthetic cannabinoid compounds became controlled by state and federal governments, different, noncontrolled compounds began to appear as marijuana substitutes. Unlike the scheduled cannabinoids, the newer compounds have not been characterized for potency and efficacy in preclinical studies. The purpose of these experiments was to determine whether some of the more recent synthetic compounds sold as marijuana substitutes have behavioral effects similar to those of Δ9-tetrahydrocannabinol (Δ9-THC), the pharmacologically active compound in marijuana. The compounds UR-144, XLR-11, AKB-48 (APINACA), PB-22 (QUPIC), 5F-PB-22, and AB-FUBINACA were tested for locomotor depressant effects in Male Swiss-Webster mice and subsequently for their ability to substitute for Δ9-THC (3 mg/kg, intraperitoneally) in drug discrimination experiments with Male Sprague-Dawley rats. UR-144, XLR-11, AKB-48, and AB-FUBINACA each decreased locomotor activity for up to 90 min, whereas PB-22 and 5F-PB-22 produced depressant effects lasting 120-150 min. Each of the compounds fully substituted for the discriminative stimulus effects of Δ9-THC. These findings confirm the suggestion that these compounds have marijuana-like psychoactive effects and abuse liability.

Original languageEnglish
Pages (from-to)460-468
Number of pages9
JournalBehavioural pharmacology
Volume26
Issue number5
DOIs
StatePublished - 8 Aug 2015

Fingerprint

Dronabinol
Cannabinoids
Cannabis
State Government
Federal Government
Locomotion
Sprague Dawley Rats
Pharmaceutical Preparations
XLR-11
N-(1-adamantyl)-1-pentylindazole-3-carboxamide
(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

Keywords

  • abuse liability
  • cannabinoids
  • drug discrimination
  • locomotor activity
  • mouse
  • rat

Cite this

@article{db936f555e6149c18247a91d9f1e370b,
title = "Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market",
abstract = "When synthetic cannabinoid compounds became controlled by state and federal governments, different, noncontrolled compounds began to appear as marijuana substitutes. Unlike the scheduled cannabinoids, the newer compounds have not been characterized for potency and efficacy in preclinical studies. The purpose of these experiments was to determine whether some of the more recent synthetic compounds sold as marijuana substitutes have behavioral effects similar to those of Δ9-tetrahydrocannabinol (Δ9-THC), the pharmacologically active compound in marijuana. The compounds UR-144, XLR-11, AKB-48 (APINACA), PB-22 (QUPIC), 5F-PB-22, and AB-FUBINACA were tested for locomotor depressant effects in Male Swiss-Webster mice and subsequently for their ability to substitute for Δ9-THC (3 mg/kg, intraperitoneally) in drug discrimination experiments with Male Sprague-Dawley rats. UR-144, XLR-11, AKB-48, and AB-FUBINACA each decreased locomotor activity for up to 90 min, whereas PB-22 and 5F-PB-22 produced depressant effects lasting 120-150 min. Each of the compounds fully substituted for the discriminative stimulus effects of Δ9-THC. These findings confirm the suggestion that these compounds have marijuana-like psychoactive effects and abuse liability.",
keywords = "abuse liability, cannabinoids, drug discrimination, locomotor activity, mouse, rat",
author = "Gatch, {Michael B.} and Forster, {Michael J.}",
year = "2015",
month = "8",
day = "8",
doi = "10.1097/FBP.0000000000000150",
language = "English",
volume = "26",
pages = "460--468",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "5",

}

TY - JOUR

T1 - Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market

AU - Gatch, Michael B.

AU - Forster, Michael J.

PY - 2015/8/8

Y1 - 2015/8/8

N2 - When synthetic cannabinoid compounds became controlled by state and federal governments, different, noncontrolled compounds began to appear as marijuana substitutes. Unlike the scheduled cannabinoids, the newer compounds have not been characterized for potency and efficacy in preclinical studies. The purpose of these experiments was to determine whether some of the more recent synthetic compounds sold as marijuana substitutes have behavioral effects similar to those of Δ9-tetrahydrocannabinol (Δ9-THC), the pharmacologically active compound in marijuana. The compounds UR-144, XLR-11, AKB-48 (APINACA), PB-22 (QUPIC), 5F-PB-22, and AB-FUBINACA were tested for locomotor depressant effects in Male Swiss-Webster mice and subsequently for their ability to substitute for Δ9-THC (3 mg/kg, intraperitoneally) in drug discrimination experiments with Male Sprague-Dawley rats. UR-144, XLR-11, AKB-48, and AB-FUBINACA each decreased locomotor activity for up to 90 min, whereas PB-22 and 5F-PB-22 produced depressant effects lasting 120-150 min. Each of the compounds fully substituted for the discriminative stimulus effects of Δ9-THC. These findings confirm the suggestion that these compounds have marijuana-like psychoactive effects and abuse liability.

AB - When synthetic cannabinoid compounds became controlled by state and federal governments, different, noncontrolled compounds began to appear as marijuana substitutes. Unlike the scheduled cannabinoids, the newer compounds have not been characterized for potency and efficacy in preclinical studies. The purpose of these experiments was to determine whether some of the more recent synthetic compounds sold as marijuana substitutes have behavioral effects similar to those of Δ9-tetrahydrocannabinol (Δ9-THC), the pharmacologically active compound in marijuana. The compounds UR-144, XLR-11, AKB-48 (APINACA), PB-22 (QUPIC), 5F-PB-22, and AB-FUBINACA were tested for locomotor depressant effects in Male Swiss-Webster mice and subsequently for their ability to substitute for Δ9-THC (3 mg/kg, intraperitoneally) in drug discrimination experiments with Male Sprague-Dawley rats. UR-144, XLR-11, AKB-48, and AB-FUBINACA each decreased locomotor activity for up to 90 min, whereas PB-22 and 5F-PB-22 produced depressant effects lasting 120-150 min. Each of the compounds fully substituted for the discriminative stimulus effects of Δ9-THC. These findings confirm the suggestion that these compounds have marijuana-like psychoactive effects and abuse liability.

KW - abuse liability

KW - cannabinoids

KW - drug discrimination

KW - locomotor activity

KW - mouse

KW - rat

UR - http://www.scopus.com/inward/record.url?scp=84938809767&partnerID=8YFLogxK

U2 - 10.1097/FBP.0000000000000150

DO - 10.1097/FBP.0000000000000150

M3 - Article

C2 - 26061356

AN - SCOPUS:84938809767

VL - 26

SP - 460

EP - 468

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 5

ER -